ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade

Shares of ADMA Biologics fell 3.7% to $18.40 in afternoon trading on Tuesday, a steeper drop than the broader biotech group. The SPDR S&P Biotech ETF was down about 1.3%.